Navigation Links
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
Date:7/8/2010

NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html

This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics. 

Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.

1: Research Objectives, Method Details, and Segmentation

1.1: Research Objectives and Method Details

Table 1: Research Objectives and Method Details

1.2: Segmentation

2: Executive Summary

2.1: Patient Compliance to Eye Care Medications

2.2: Factors Impacting Eye Care Medication Prescriptions

2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

3: Patient Compliance with Eye Care Medications

3.1: Assessment of Patient Compliance

3.2: Analyst Comments

3.3: Average Number of Medications Taken by Glaucoma Patients

4: Factors Impacting Prescriptions of Eye Care Medications

4.1: Eye Care Medications: Most Important Features

4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications

4.3: Patients' Involvement in Eye Care Medication Selection Process

5: Preferences for Glaucoma Medications

5.1: Prostaglandin Analogues for Glaucoma

5.1.1: Primary Brand Use and Brand Reputation

5.1.2: Brand Loyalty

5.2: Beta Blockers for Glaucoma

5.2.1: Primary Brand Use and Brand Reputation

5.2.2: Brand Loyalty

5.3: Combination Therapies for Glaucoma

5.3.1: Primary Brand Use and Brand Reputation

5.3.2: Brand Loyalty

5.4: Carbonic Anhydrase Inhibitors for Glaucoma

5.4.1: Primary Brand Use and Brand Reputation

5.4.2: Brand Loyalty

5.5: Alpha Adrenergic Agonists for Glaucoma

5.5.1: Primary Brand Use and Brand Reputation

6: Preferences for Other Eye Disease Medications

6.1: Age-Related Macular Degeneration Medications

6.1.1: Primary Brand Use and Brand Reputation

6.1.2: Brand Loyalty

6.1.3: Lucentis Versus Avastin

6.2: Allergic Conjunctivitis Medications

6.2.1: Primary Brand Use and Brand Reputation

6.2.2: Brand Loyalty

6.3: NSAID Medications

6.3.1: Primary Brand Use and Brand Reputation

6.3.2: Brand Loyalty

7: Appendices

7.1: Preferences for Glaucoma Medications

7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.2: Preferences for Other Eye Disease Medications

7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments

To order this report:

Drug and Medication Industry:

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):